chr1-155085361-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_004952.5(EFNA3):āc.399T>Gā(p.Ser133=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00437 in 1,612,022 control chromosomes in the GnomAD database, including 273 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.023 ( 146 hom., cov: 33)
Exomes š: 0.0024 ( 127 hom. )
Consequence
EFNA3
NM_004952.5 synonymous
NM_004952.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0650
Genes affected
EFNA3 (HGNC:3223): (ephrin A3) This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 1-155085361-T-G is Benign according to our data. Variant chr1-155085361-T-G is described in ClinVar as [Benign]. Clinvar id is 775143.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.065 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0776 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFNA3 | NM_004952.5 | c.399T>G | p.Ser133= | synonymous_variant | 2/5 | ENST00000368408.4 | NP_004943.1 | |
EFNA4-EFNA3 | NM_001407761.1 | c.384T>G | p.Ser128= | synonymous_variant | 2/5 | NP_001394690.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFNA3 | ENST00000368408.4 | c.399T>G | p.Ser133= | synonymous_variant | 2/5 | 1 | NM_004952.5 | ENSP00000357393 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0230 AC: 3508AN: 152226Hom.: 144 Cov.: 33
GnomAD3 genomes
AF:
AC:
3508
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00595 AC: 1453AN: 244378Hom.: 53 AF XY: 0.00441 AC XY: 585AN XY: 132794
GnomAD3 exomes
AF:
AC:
1453
AN:
244378
Hom.:
AF XY:
AC XY:
585
AN XY:
132794
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00242 AC: 3532AN: 1459676Hom.: 127 Cov.: 32 AF XY: 0.00213 AC XY: 1549AN XY: 725972
GnomAD4 exome
AF:
AC:
3532
AN:
1459676
Hom.:
Cov.:
32
AF XY:
AC XY:
1549
AN XY:
725972
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0231 AC: 3519AN: 152346Hom.: 146 Cov.: 33 AF XY: 0.0225 AC XY: 1675AN XY: 74502
GnomAD4 genome
AF:
AC:
3519
AN:
152346
Hom.:
Cov.:
33
AF XY:
AC XY:
1675
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at